Investment Summary |
|
|---|---|
| Date | 2024-02-07 |
| Target | n6 |
| Sector | Life Science |
| Investor(s) | Telegraph Hill Partners |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Venture Capital Firm |
|---|---|
| Founded | 2001 |
| Size | Middle-Market |
| Type | Sector Focused |
Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 34 of 34 |
| Sector: Life Science M&A | 13 of 13 |
| Type: Growth Capital M&A Deals | 4 of 4 |
| State: California M&A | 17 of 17 |
| Country: United States M&A | 31 of 31 |
| Year: 2024 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-01-09 |
Verogen
San Diego, California, United States Verogen is a developer, manufacturer, and sells forensic genomics products and services, including for next-generation sequencing. Verogen was formed in 2017 and is based in San Diego, California. |
Sell | $150M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2024-12-13 |
Nimble Therapeutics
Madison, Wisconsin, United States Nimble Therapeutics is a provider of massively parallel chemical synthesis to drug discovery. Nimble’s proprietary technology enables the synthesis and screening of millions of peptides, including scaffolded natural and modified macrocyclic peptidomimetics. Nimble Therapeutics was founded in 2019 and is based in Madison, Wisconsin. |
Sell | - |
